The Treatment of Heroin Addiction: Naltrexone Alone and with Behavior Therapy

References

• Blanchard E. B., Libet J. M., Young L. D. Apneic aversion and covert sensitization in the treatment of hydrocarbon inhalation addiction: A case study. J. Behav. Ther. Exp. Psychiatry 1973; 4: 383–387
   Web of Science ®Google Scholar
• Boudin H. M. Contingency contracting as a therapeutic tool in the deceleration of amphetamine use. Behav. Ther 1972; 3: 604–605
   Web of Science ®Google Scholar
• Boudin H. M., Regan E. J., Ruiz M. R. Contingency Contracting with Drug Abusers in the Natural Environment. Paper presented at the Symposium on Behavior Therapy in Heroin Addiction Clinics: Current Outcome Evaluations, 84th Meeting of the American Psychology Association, Washington, DC, 1976
   Google Scholar
• Boudin H. M., Valentine V. E. Contingency Contracting: A Major Treatment Modality for Drug Abuse. Paper presented at Sixth Annual Meeting of the Association for Advancement of Behavior Therapy, New York, 1972
   Google Scholar
• Boudin H. M., Valentine V. E., Ingrahan R. D., Brantley J. M., Ruiz M. R., Smith G. G., Catlin R. P., Regan E. J. Contingency contracting with drug abusers in the natural environment. Int. J. Addict 1977; 12: 1–16
   PubMedGoogle Scholar
• Bradford H. A., Hurley F. L., Golondzowski O., Dorrier C. Interim report on clinic intake and safety data collected from 17 Nida-funded naltrexone studies. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault. NIDA Research Monograph, Washington, DC 1976; 163–171
   Google Scholar
• Callahan E. J., Price K., Dahlkoetter J. Drug abuse: Issues and experience in behavioral intervention. Clinical Behavior Modification and Therapy, R. Daitzman. Garland Press, New York 1980; 175–248
   Google Scholar
• Callahan E. J., Rawson R. A. Behavioral assessment of narcotic addiction treatment outcome. Outcome Evaluation in Alcohol and Drug Abuse Treatment, L. C. Sobell, M. B. Sobell. Plenum, New York 1980; 77–92
   Google Scholar
• Callahan E. J., Rawson R. A., Glazer M., McCleave B. A., Arias R. Comparison of two naltrexone treatment programs: Naltrexone alone versus naltrexone plus behavior therapy. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault. NIDA Research Monograph, Washington, DC 1976; 150–157
   Google Scholar
• Callner D. A. Behavioral treatment approaches to drug abuse: A critical review of the research. Psychol. Bull 1975; 82: 143–162
   PubMed Web of Science ®Google Scholar
• Dole V. P., Nyswander M. A. Medical treatment for diacetyl morphine (heroin) addiction. J. Am. Med. Assoc 1965; 193: 646–650
   PubMed Web of Science ®Google Scholar
• Droppa D. C. Behavioral treatment of drug addiction: A review and analysis. Int. J. Addict 1973; 8: 143–161
   PubMed Web of Science ®Google Scholar
• Freedman A. M., Fink M., Sharoff R., Zaks A. Cyclazocine and methadone in the treatment of narcotic addiction. J. Am. Med. Assoc 1967; 202: 191–194
   PubMed Web of Science ®Google Scholar
• Greenstein R., O'Brien C., Mintz J., Woody G. E., Hanna N. Clinical experience with naltrexone in a behavioral research study: An interim report. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault. NIDA Research Monograph, Washington, DC 1976; 141–149
   Google Scholar
• Hurzeler M., Gerwirtz D., Kleber H. Varying clinical contexts for administering naltrexone. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault, Washington, DC 1976; 48–66, NIDA Research Monograph
   Google Scholar
• Jasinski D. R., Martin W. R., Haertzen C. A. The human pharmacology and abuse potential of n-allylnoroxymorphone (naltrexone). J. Pharmacol. Ther 1967; 157: 420–426
   PubMed Web of Science ®Google Scholar
• Kleber H., Kinsella J. K., Riordan C., Greaves S., Sweeny D. The use of cyclazocine in treating narcotic addicts in a low intervention setting. Arch. Gen. Psychiatry 1974; 30: 37–42
   PubMed Web of Science ®Google Scholar
• Liberman R. P. Aversive conditioning of drug addicts: A pilot study. Behav. Res. Ther 1968; 6: 229–231
   PubMed Web of Science ®Google Scholar
• Martin W. R. Naltrexone, an antagonist for the treatment of heroin dependence: Effects in man. Arch. Gen Psychiatry 1973; 28: 784–791
   PubMed Web of Science ®Google Scholar
• Martin W. R. Treatment of heroin dependence with naltrexone. Curr. Psychiatr. Ther 1975; 15: 157–161
   PubMedGoogle Scholar
• O'Brien C. P., Greenstein R., Mintz J., Woody G. Clinical experience with naltrexone. Am. J. Drug Alcohol Abuse 1975; 2(3)363–377
   Web of Science ®Google Scholar
• Overton D. A. State-dependent or “dissociated” learning produced with pentobarbital. J. Comp. Plrysiol. Psychol 1964; 57: 3–12
   PubMed Web of Science ®Google Scholar
• Rawson R. A., Callahan E. J., Liberman R. P. Preliminary Comparison of Behavior Therapy and Naltrexone in the Treatment of Heroin Addiction. Paper presented at the Symposium on Current Appraisal of Behavior Therapy Programs in Heroin Addiction, 84th Annual Convention of the American Psychological Association, Washington, DC, 1976
   Google Scholar
• Resnick R. B., Aronoff M., Lonburg G., Kastenbaum R., Kauders F., Washington A., Hough G. Clinical efficacy of naltrexone: A one year follow-up. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault, Washington, DC 1976; 114–119, NIDA Research Monograph
   Google Scholar
• Resnick R., Fink M., Freedman A. M. Cyclazocine treatment of opiate addiction: A progress report. Comp. Psychiatry 1971; 12: 491–502
   PubMed Web of Science ®Google Scholar
• Resnick R., Volavka J., Freedman A. M., Thomas M. Studies of EN-1693A (naltrexone): A new narcotic antagonist. Am. J. Psychiatry 1974; 131: 646–650
   PubMed Web of Science ®Google Scholar
• Steinfeld G. The use of covert sensitization with institutionalized narcotic addicts. Int. J. Addict 1970; 5: 225–232
   PubMed Web of Science ®Google Scholar
• Thompson I. G., Rathod N. H. Aversion therapy for heroin dependence. Lancet 1968; 2: 382–384
   PubMed Web of Science ®Google Scholar
• Wikler A. Conditioning factors in opiate addiction and relapse. Narcotics, D. M. Milner, G. G. Kasenbaum. McGraw-Hill, New York 1965; 85–100
   Google Scholar
• Wikler A. Methadone maintenance and narcotic blocking drugs. Int. J. Addict 1977; 12: 851–856
   PubMed Web of Science ®Google Scholar
• Wisocki P. A. The successful treatment of heroin addiction by covert conditioning techniques. J. Behav. They. Exp. Psychiatry 1973; 4: 55–62
   Web of Science ®Google Scholar
• Yablonsky L. The Tunnel Back. Macmillan, New York 1965
   Google Scholar
• Zaks A., Jones T., Fink M., Freedman A. M. Naltrexone treatment of opiate dependence. J. Am. Med. Assoc 1967; 202: 191–194
   Google Scholar